1. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis. Issue 10 (5th October 2013) Authors: Kennedy, N. A.; Rhatigan, E.; Arnott, I. D. R.; Noble, C. L.; Shand, A. G.; Satsangi, J.; Lees, C. W. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 10(2013) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. H1‐antihistamines for primary mast cell activation syndromes: a systematic review. Issue 9 (6th July 2015) Authors: Nurmatov, U. B.; Rhatigan, E.; Simons, F. E. R.; Sheikh, A. Journal: Allergy Issue: Volume 70:Issue 9(2015:Sep.) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗